Maliwong J.; Chimnoi N.; Ruchirawat S.; Kanchanapoom T. Phenolic Glycosides from the Roots of Molineria latifolia. Phytochem. Lett. 2021, 46, 90-94.

01 Dec 2021
0
0

Maliwong J.; Chimnoi N.; Ruchirawat S.; Kanchanapoom T. Phenolic Glycosides from the Roots of Molineria latifolia. Phytochem. Lett. 2021, 46, 90-94.

Tags

Share this

Related Posts

Perfluorinated chemicals, PFOS and PFOA, enhance the estrogenic effects of 17 β –estradiol in T47D human breast cancer cells. Sonthithai P, Suriyo T, Thiantanawat A, Watcharasit P, Ruchirawat M, Satayavivad J. J Applied Toxicol 2016; 36: 790-801.
01 Jun 2016
0

Perfluorinated chemicals, PFOS and PFOA, enhance the estrogenic effects of 17 β –estradiol in T47D human breast cancer cells. Sonthithai P, Suriyo T, Thiantanawat A, Watcharasit P, Ruchirawat M, Satayavivad J. J Applied Toxicol 2016; 36: 790-801.

Perfluorinated chemicals, PFOS and PFOA, enhance the estrogenic effects of 17 β –estradiol in T47D human breast cancer cells. Sonthithai P, Suriyo T, Thiantanawat A, Watcharasit P, Ruchirawat M, Satayavivad J. J Applied Toxicol 2016; 36: 790-801.
View More
Epigallocatechin gallate-zinc oxide co-crystalline nanoparticles as an anticancer drug that is non-toxic to normal cells. Samutprasert P, Chiablaem K, Teeraseranee C, Phaiyarin P, Pukfukdee P, Pienpinijtham P, Svasti J, Palaga T, Lirdprapamongkol K, Wanichwecharungruang S*. RSC Adv. 2018;8(14):7369-7376
15 Feb 2018
0

Epigallocatechin gallate-zinc oxide co-crystalline nanoparticles as an anticancer drug that is non-toxic to normal cells. Samutprasert P, Chiablaem K, Teeraseranee C, Phaiyarin P, Pukfukdee P, Pienpinijtham P, Svasti J, Palaga T, Lirdprapamongkol K, Wanichwecharungruang S*. RSC Adv. 2018;8(14):7369-7376

Epigallocatechin gallate-zinc oxide co-crystalline nanoparticles as an anticancer drug that is non-toxic to normal cells. Samutprasert P, Chiablaem K, Teeraseranee C, Phaiyarin P, Pukfukdee P, Pienpinijtham P, Svasti J, Palaga T, Lirdprapamongkol K, Wanichwecharungruang S*. RSC Adv. 2018;8(14):7369-7376
View More

Recent Posts

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)
20 Sep 2023
0

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial) Siripongboonsitti T, Ungtrakul T, Tawinprai K, Auewarakul C, Chartisathian W, Jansala T, Julsawad R, Soonklang K, Mahanonda N, Mahidol C Phytomedicine. 2023;119:155018.
View More